Applied Therapeutics
APLT
APLT was delisted on the 2nd of February, 2026.
44 hedge funds and large institutions have $17.1M invested in Applied Therapeutics in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 13 closing their positions.
207,200% more call options, than puts
Call options by funds: $4.15M | Put options by funds: $2K
17% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 12
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10.61% less ownership
Funds ownership: 57.83% → 47.22% (-11%)
17% less funds holding
Funds holding: 53 → 44 (-9)
21% less capital invested
Capital invested by funds: $21.6M → $17.1M (-$4.46M)
69% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$203K |
| 2 |
Two Sigma Advisers
New York
|
+$164K |
| 3 |
Citigroup
New York
|
+$111K |
| 4 |
Renaissance Technologies
New York
|
+$84.1K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$60K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.37M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.34M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$964K |
| 4 |
EAM
Empery Asset Management
New York
|
-$640K |
| 5 |
Millennium Management
New York
|
-$313K |
APLT Hedge Fund Activity: Q3 2022 in Review
44 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q3 2022, worth a combined $17.1M — down 21% from $21.6M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of APLT and 4 opened new positions — a net loss of 9 holders — while 12 trimmed existing stakes and 14 added.
The largest buyer was Geode Capital Management, adding an estimated $203K. The largest seller was Alyeska Investment Group, cutting an estimated $1.37M.
- 44 institutional investors held Applied Therapeutics (APLT) as of Q3 2022, down from 53 in Q2 2022.
- Funds reported $17.1M of Applied Therapeutics stock for Q3 2022, down 21% quarter-over-quarter.
- 4 funds opened new Applied Therapeutics positions in Q3 2022 and 13 closed out, a net change of -9 holders.
- The largest Applied Therapeutics buyer in Q3 2022 was Geode Capital Management, an estimated $203K added.
- The largest Applied Therapeutics seller in Q3 2022 was Alyeska Investment Group, an estimated $1.37M sold.
Based on aggregated 13F filings for Q3 2022.